Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smith-Lemli-Opitz Syndrome | 22 | 2017 | 46 | 2.300 |
Why?
|
Abnormalities, Multiple | 24 | 2017 | 1424 | 1.260 |
Why?
|
Certification | 4 | 2018 | 420 | 0.990 |
Why?
|
Cholesterol | 19 | 2010 | 2914 | 0.640 |
Why?
|
Developmental Disabilities | 10 | 2011 | 1518 | 0.580 |
Why?
|
Specialty Boards | 3 | 2016 | 235 | 0.580 |
Why?
|
Chromosome Deletion | 8 | 2011 | 1385 | 0.560 |
Why?
|
Chromosome Aberrations | 7 | 2016 | 1778 | 0.560 |
Why?
|
Neurofibromatosis 1 | 9 | 2013 | 561 | 0.520 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 10 | 2012 | 173 | 0.450 |
Why?
|
Metabolism, Inborn Errors | 4 | 2004 | 292 | 0.440 |
Why?
|
Genetics, Medical | 4 | 2012 | 334 | 0.390 |
Why?
|
Education, Medical, Continuing | 4 | 2018 | 829 | 0.370 |
Why?
|
Trisomy | 4 | 2005 | 260 | 0.360 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2006 | 2521 | 0.330 |
Why?
|
Growth Disorders | 5 | 2009 | 635 | 0.320 |
Why?
|
Genetic Services | 1 | 2008 | 13 | 0.320 |
Why?
|
Microarray Analysis | 1 | 2011 | 753 | 0.310 |
Why?
|
Neonatal Screening | 3 | 2004 | 620 | 0.300 |
Why?
|
Genetic Testing | 8 | 2011 | 3591 | 0.290 |
Why?
|
Clinical Competence | 4 | 2018 | 4858 | 0.280 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2665 | 0.280 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2007 | 115 | 0.260 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 323 | 0.250 |
Why?
|
Physicians | 2 | 2022 | 4598 | 0.250 |
Why?
|
Dehydrocholesterols | 8 | 2012 | 20 | 0.240 |
Why?
|
Arteriovenous Fistula | 1 | 2007 | 320 | 0.220 |
Why?
|
Telomere | 3 | 2004 | 944 | 0.220 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3800 | 0.220 |
Why?
|
Consumer Advocacy | 1 | 2003 | 83 | 0.210 |
Why?
|
Child, Preschool | 39 | 2017 | 42669 | 0.200 |
Why?
|
Workload | 1 | 2008 | 849 | 0.200 |
Why?
|
PTEN Phosphohydrolase | 2 | 2010 | 1120 | 0.200 |
Why?
|
Genome, Human | 2 | 2021 | 4446 | 0.190 |
Why?
|
Blood Vessels | 1 | 2007 | 1110 | 0.190 |
Why?
|
Quality Improvement | 2 | 2016 | 3857 | 0.190 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2001 | 82 | 0.190 |
Why?
|
Lipid Metabolism, Inborn Errors | 3 | 2001 | 123 | 0.180 |
Why?
|
Child | 47 | 2013 | 80917 | 0.180 |
Why?
|
Infant | 33 | 2017 | 36535 | 0.170 |
Why?
|
Infant, Newborn | 25 | 2017 | 26422 | 0.170 |
Why?
|
Cytodiagnosis | 1 | 2003 | 452 | 0.170 |
Why?
|
Technology | 1 | 2022 | 296 | 0.160 |
Why?
|
Medicine | 2 | 2018 | 945 | 0.150 |
Why?
|
Bile Acids and Salts | 4 | 1997 | 398 | 0.150 |
Why?
|
Moyamoya Disease | 2 | 2013 | 274 | 0.150 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 2010 | 348 | 0.150 |
Why?
|
Syndrome | 14 | 2010 | 3272 | 0.150 |
Why?
|
Fetal Diseases | 3 | 1999 | 916 | 0.150 |
Why?
|
Phenylketonurias | 3 | 1993 | 128 | 0.150 |
Why?
|
Educational Measurement | 2 | 2016 | 1260 | 0.140 |
Why?
|
Oxidoreductases | 7 | 2000 | 410 | 0.140 |
Why?
|
Genes, Recessive | 2 | 1996 | 625 | 0.140 |
Why?
|
Intelligence | 1 | 2022 | 926 | 0.140 |
Why?
|
Phenotype | 12 | 2012 | 16726 | 0.130 |
Why?
|
Prenatal Diagnosis | 3 | 1999 | 1275 | 0.130 |
Why?
|
Gene Duplication | 2 | 2006 | 315 | 0.120 |
Why?
|
Karyotyping | 4 | 2011 | 1177 | 0.120 |
Why?
|
Congenital Abnormalities | 3 | 2016 | 703 | 0.120 |
Why?
|
Nucleic Acid Hybridization | 2 | 2007 | 1305 | 0.120 |
Why?
|
Chromosomes, Human, Pair 2 | 3 | 2006 | 313 | 0.110 |
Why?
|
Humans | 86 | 2022 | 768166 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 3780 | 0.110 |
Why?
|
Amniocentesis | 2 | 2006 | 116 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 3 | 2004 | 534 | 0.100 |
Why?
|
Chromosome Disorders | 2 | 2014 | 498 | 0.100 |
Why?
|
Sterols | 4 | 1997 | 64 | 0.100 |
Why?
|
Hirschsprung Disease | 2 | 2005 | 163 | 0.100 |
Why?
|
Bone Diseases, Developmental | 1 | 2013 | 132 | 0.100 |
Why?
|
Hyperventilation | 1 | 2011 | 78 | 0.100 |
Why?
|
Neurofibroma, Plexiform | 1 | 2012 | 66 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1146 | 0.090 |
Why?
|
Segmental Duplications, Genomic | 1 | 2011 | 20 | 0.090 |
Why?
|
Connexins | 2 | 2003 | 355 | 0.090 |
Why?
|
Male | 50 | 2017 | 364719 | 0.090 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 169 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2603 | 0.090 |
Why?
|
Electroretinography | 2 | 2010 | 524 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2011 | 275 | 0.090 |
Why?
|
Adolescent | 26 | 2013 | 89169 | 0.090 |
Why?
|
Cafe-au-Lait Spots | 1 | 2009 | 20 | 0.090 |
Why?
|
Cerebral Revascularization | 1 | 2013 | 260 | 0.090 |
Why?
|
Congenital Hypothyroidism | 2 | 2004 | 40 | 0.080 |
Why?
|
Galactosemias | 2 | 1993 | 126 | 0.080 |
Why?
|
Female | 52 | 2017 | 397192 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2011 | 598 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 438 | 0.080 |
Why?
|
Limb Deformities, Congenital | 2 | 2005 | 136 | 0.080 |
Why?
|
Health Personnel | 1 | 2003 | 3385 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 325 | 0.080 |
Why?
|
Chromosome Banding | 2 | 2006 | 261 | 0.080 |
Why?
|
Gene Dosage | 3 | 2010 | 1219 | 0.080 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2010 | 183 | 0.080 |
Why?
|
Deafness | 2 | 2003 | 460 | 0.080 |
Why?
|
Maple Syrup Urine Disease | 2 | 2002 | 41 | 0.080 |
Why?
|
Learning | 1 | 2018 | 1759 | 0.080 |
Why?
|
Publishing | 1 | 2016 | 837 | 0.080 |
Why?
|
Skull | 1 | 2013 | 820 | 0.080 |
Why?
|
Time and Motion Studies | 1 | 2008 | 143 | 0.080 |
Why?
|
DNA Copy Number Variations | 2 | 2014 | 2048 | 0.070 |
Why?
|
Osteochondrodysplasias | 1 | 2009 | 183 | 0.070 |
Why?
|
TRPV Cation Channels | 1 | 2009 | 244 | 0.070 |
Why?
|
Facies | 3 | 2011 | 224 | 0.070 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1987 | 96 | 0.070 |
Why?
|
Face | 3 | 2005 | 1029 | 0.070 |
Why?
|
Pregnancy | 10 | 2012 | 30256 | 0.070 |
Why?
|
DNA Helicases | 1 | 2011 | 854 | 0.070 |
Why?
|
Mutation, Missense | 4 | 2009 | 2592 | 0.060 |
Why?
|
Melanosis | 1 | 2007 | 93 | 0.060 |
Why?
|
Twins, Dizygotic | 1 | 2006 | 236 | 0.060 |
Why?
|
Menkes Kinky Hair Syndrome | 2 | 2000 | 18 | 0.060 |
Why?
|
Brain Stem Neoplasms | 1 | 2007 | 191 | 0.060 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 2005 | 29 | 0.060 |
Why?
|
Case Management | 1 | 2007 | 277 | 0.060 |
Why?
|
Glioblastoma | 2 | 2010 | 3464 | 0.060 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2006 | 183 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2007 | 620 | 0.060 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 192 | 0.060 |
Why?
|
Leucovorin | 1 | 1987 | 643 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2010 | 709 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5926 | 0.060 |
Why?
|
Hypothyroidism | 2 | 2004 | 667 | 0.060 |
Why?
|
Toxoplasmosis, Congenital | 1 | 2004 | 8 | 0.060 |
Why?
|
Language Development Disorders | 3 | 2011 | 194 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2006 | 447 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2008 | 635 | 0.060 |
Why?
|
Neurofibroma | 1 | 2004 | 95 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2005 | 411 | 0.060 |
Why?
|
Sequence Deletion | 2 | 2010 | 1497 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2017 | 81762 | 0.060 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1375 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2010 | 1407 | 0.050 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2007 | 386 | 0.050 |
Why?
|
United States | 6 | 2016 | 73039 | 0.050 |
Why?
|
Microcephaly | 3 | 2004 | 426 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2055 | 0.050 |
Why?
|
Hydrogen | 1 | 2003 | 171 | 0.050 |
Why?
|
Craniosynostoses | 1 | 2007 | 415 | 0.050 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1986 | 283 | 0.050 |
Why?
|
Nose | 1 | 2006 | 522 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 18065 | 0.050 |
Why?
|
Memory Disorders | 1 | 2010 | 1200 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2010 | 1835 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2004 | 435 | 0.050 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2003 | 204 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2846 | 0.050 |
Why?
|
Hemangioma | 1 | 2007 | 727 | 0.050 |
Why?
|
Cholestadienols | 2 | 1998 | 5 | 0.050 |
Why?
|
Acyl-CoA Dehydrogenases | 1 | 2001 | 24 | 0.050 |
Why?
|
Tyrosine | 1 | 1986 | 1427 | 0.050 |
Why?
|
Head | 1 | 2007 | 926 | 0.050 |
Why?
|
Laryngeal Neoplasms | 1 | 2004 | 514 | 0.050 |
Why?
|
Fatty Acid Desaturases | 1 | 2001 | 102 | 0.050 |
Why?
|
Biotinidase | 2 | 1993 | 17 | 0.040 |
Why?
|
Disease Management | 1 | 2011 | 2536 | 0.040 |
Why?
|
Rhombencephalon | 1 | 2000 | 81 | 0.040 |
Why?
|
Vision, Ocular | 1 | 2003 | 458 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2056 | 0.040 |
Why?
|
Heterozygote | 4 | 2001 | 2798 | 0.040 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 267 | 0.040 |
Why?
|
Homocystinuria | 2 | 1993 | 65 | 0.040 |
Why?
|
Mutation | 7 | 2010 | 30238 | 0.040 |
Why?
|
Young Adult | 8 | 2013 | 60066 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2892 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 2000 | 0.040 |
Why?
|
Amidohydrolases | 2 | 1993 | 160 | 0.040 |
Why?
|
Estriol | 1 | 1999 | 53 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 1986 | 684 | 0.040 |
Why?
|
Skin Diseases | 2 | 1997 | 1085 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2010 | 474 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3327 | 0.040 |
Why?
|
DNA Mutational Analysis | 5 | 2009 | 4120 | 0.040 |
Why?
|
Radiography | 3 | 2007 | 6983 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 4249 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2001 | 542 | 0.040 |
Why?
|
Glycine | 1 | 2001 | 672 | 0.040 |
Why?
|
Brain | 2 | 2003 | 27360 | 0.040 |
Why?
|
Cholesterol, Dietary | 2 | 1997 | 224 | 0.040 |
Why?
|
Retinal Diseases | 1 | 2003 | 710 | 0.040 |
Why?
|
Gene Deletion | 1 | 2005 | 2675 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12795 | 0.030 |
Why?
|
Testicular Hydrocele | 1 | 1996 | 27 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5804 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2202 | 0.030 |
Why?
|
American Medical Association | 1 | 2016 | 60 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2007 | 3329 | 0.030 |
Why?
|
Adult | 17 | 2013 | 223646 | 0.030 |
Why?
|
Amniotic Fluid | 1 | 1998 | 381 | 0.030 |
Why?
|
Alopecia | 1 | 2000 | 416 | 0.030 |
Why?
|
Plasma | 1 | 1999 | 585 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2000 | 969 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 1995 | 174 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6669 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2009 | 7876 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2001 | 2227 | 0.030 |
Why?
|
Gestational Age | 2 | 2001 | 3621 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 2 | 2001 | 1772 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2011 | 2909 | 0.030 |
Why?
|
Ursodeoxycholic Acid | 1 | 1994 | 81 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6082 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1996 | 452 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9263 | 0.030 |
Why?
|
Fatty Acids | 1 | 2001 | 1812 | 0.030 |
Why?
|
Cerebellum | 1 | 2000 | 1522 | 0.030 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 1993 | 98 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 1997 | 6316 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1836 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2002 | 1791 | 0.030 |
Why?
|
Microsatellite Repeats | 2 | 2005 | 785 | 0.030 |
Why?
|
Base Sequence | 1 | 2003 | 12421 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2007 | 36743 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12168 | 0.020 |
Why?
|
Angiography | 1 | 2017 | 1597 | 0.020 |
Why?
|
Proteins | 1 | 2006 | 6009 | 0.020 |
Why?
|
Internship and Residency | 1 | 2012 | 5953 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 14 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2011 | 13014 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1997 | 1443 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 97 | 0.020 |
Why?
|
Fibroblasts | 1 | 2001 | 4176 | 0.020 |
Why?
|
Autistic Disorder | 2 | 2010 | 1240 | 0.020 |
Why?
|
Genetic Association Studies | 2 | 2010 | 2744 | 0.020 |
Why?
|
Lymphedema | 1 | 1996 | 527 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2011 | 392 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2007 | 22291 | 0.020 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2009 | 74 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2010 | 208 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2004 | 4712 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 9118 | 0.020 |
Why?
|
Pterygium | 1 | 1988 | 24 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2010 | 343 | 0.020 |
Why?
|
Self-Help Groups | 1 | 1990 | 194 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 937 | 0.020 |
Why?
|
Abortion, Legal | 1 | 1990 | 121 | 0.020 |
Why?
|
Abortion, Habitual | 1 | 1988 | 63 | 0.020 |
Why?
|
Behavior | 2 | 2003 | 542 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2003 | 15948 | 0.020 |
Why?
|
5-Hydroxytryptophan | 1 | 1987 | 33 | 0.020 |
Why?
|
Carbidopa | 1 | 1987 | 30 | 0.020 |
Why?
|
Body Dysmorphic Disorders | 1 | 2011 | 243 | 0.020 |
Why?
|
Bone and Bones | 1 | 1997 | 2589 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2011 | 606 | 0.020 |
Why?
|
Hartnup Disease | 1 | 1986 | 4 | 0.020 |
Why?
|
Steryl-Sulfatase | 1 | 1986 | 11 | 0.020 |
Why?
|
Albinism | 1 | 1986 | 25 | 0.020 |
Why?
|
Homozygote | 3 | 1995 | 1779 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2130 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1903 | 0.020 |
Why?
|
Alkaptonuria | 1 | 1986 | 13 | 0.020 |
Why?
|
Sulfatases | 1 | 1986 | 44 | 0.020 |
Why?
|
Porphyrias | 1 | 1986 | 57 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18412 | 0.020 |
Why?
|
Levodopa | 1 | 1987 | 221 | 0.020 |
Why?
|
Galactosephosphates | 1 | 1985 | 9 | 0.020 |
Why?
|
Keratosis | 1 | 1986 | 81 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4620 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39348 | 0.020 |
Why?
|
Speech Disorders | 1 | 2006 | 179 | 0.020 |
Why?
|
Parietal Bone | 1 | 2005 | 49 | 0.020 |
Why?
|
Craniofacial Dysostosis | 1 | 2005 | 74 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1993 | 1065 | 0.020 |
Why?
|
Physical Chromosome Mapping | 1 | 2005 | 183 | 0.020 |
Why?
|
Pharyngectomy | 1 | 2004 | 45 | 0.010 |
Why?
|
Carbohydrate Metabolism | 1 | 1986 | 262 | 0.010 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 320 | 0.010 |
Why?
|
Echocardiography | 1 | 2017 | 5047 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 1993 | 1294 | 0.010 |
Why?
|
Peer Group | 1 | 1990 | 700 | 0.010 |
Why?
|
Tracheotomy | 1 | 2004 | 174 | 0.010 |
Why?
|
Cytogenetic Analysis | 1 | 2004 | 271 | 0.010 |
Why?
|
Urea | 1 | 1986 | 448 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2006 | 737 | 0.010 |
Why?
|
Eczema | 1 | 1986 | 245 | 0.010 |
Why?
|
Kidney | 1 | 1999 | 7064 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1985 | 454 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 1987 | 663 | 0.010 |
Why?
|
Laryngectomy | 1 | 2004 | 245 | 0.010 |
Why?
|
Milk | 1 | 1985 | 438 | 0.010 |
Why?
|
Neural Crest | 1 | 2005 | 278 | 0.010 |
Why?
|
Heart Murmurs | 1 | 2002 | 92 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2735 | 0.010 |
Why?
|
Pregnancy Outcome | 2 | 2006 | 2972 | 0.010 |
Why?
|
Prevalence | 2 | 2011 | 15869 | 0.010 |
Why?
|
Infant Food | 1 | 2002 | 139 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14783 | 0.010 |
Why?
|
Linoleoyl-CoA Desaturase | 1 | 2001 | 4 | 0.010 |
Why?
|
Chromosome Painting | 1 | 2001 | 26 | 0.010 |
Why?
|
Chorionic Villi Sampling | 1 | 2001 | 35 | 0.010 |
Why?
|
Lymphangioma, Cystic | 1 | 2001 | 34 | 0.010 |
Why?
|
Steroids | 1 | 2006 | 938 | 0.010 |
Why?
|
Dicarboxylic Acids | 1 | 2001 | 75 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1327 | 0.010 |
Why?
|
Aneuploidy | 1 | 2004 | 573 | 0.010 |
Why?
|
Caprylates | 1 | 2001 | 115 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2810 | 0.010 |
Why?
|
Alleles | 2 | 2002 | 6894 | 0.010 |
Why?
|
Carnitine | 1 | 2001 | 253 | 0.010 |
Why?
|
Folic Acid | 1 | 1987 | 1337 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2954 | 0.010 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2001 | 225 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6526 | 0.010 |
Why?
|
Amino Acids | 1 | 1986 | 1716 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2012 | 26379 | 0.010 |
Why?
|
Middle Aged | 4 | 2009 | 223492 | 0.010 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2002 | 267 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2000 | 766 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2004 | 714 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2004 | 1394 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2004 | 914 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6314 | 0.010 |
Why?
|
alpha-Fetoproteins | 1 | 1999 | 229 | 0.010 |
Why?
|
Genotype | 2 | 2005 | 13045 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9538 | 0.010 |
Why?
|
Down Syndrome | 1 | 2006 | 919 | 0.010 |
Why?
|
Animals | 5 | 2011 | 169246 | 0.010 |
Why?
|
Laser Therapy | 1 | 2004 | 1107 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1998 | 354 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1534 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4413 | 0.010 |
Why?
|
Endocrine Glands | 1 | 1997 | 101 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1999 | 458 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 4937 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11095 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8741 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2013 | 65371 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6329 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 2002 | 802 | 0.010 |
Why?
|
Ribs | 1 | 1997 | 259 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 1997 | 3728 | 0.010 |
Why?
|
Piperazines | 2 | 1997 | 2554 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 2000 | 651 | 0.010 |
Why?
|
Ultrasonography | 1 | 1988 | 6004 | 0.010 |
Why?
|
Growth | 1 | 1997 | 366 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2002 | 1542 | 0.010 |
Why?
|
Arm | 1 | 1997 | 591 | 0.010 |
Why?
|
Fetal Death | 1 | 1996 | 434 | 0.010 |
Why?
|
Exons | 1 | 2000 | 2394 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13671 | 0.010 |
Why?
|
Failure to Thrive | 1 | 1994 | 139 | 0.010 |
Why?
|
Dietary Fats | 1 | 2001 | 2003 | 0.010 |
Why?
|
Cohort Studies | 2 | 2007 | 41754 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2002 | 1334 | 0.010 |
Why?
|
Leg | 1 | 1997 | 1088 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1995 | 557 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2001 | 1399 | 0.010 |
Why?
|
Schizophrenia | 1 | 2010 | 6983 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4786 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 30010 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40218 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 15597 | 0.010 |
Why?
|
Reference Values | 1 | 1998 | 4938 | 0.010 |
Why?
|
Cataract | 1 | 1997 | 837 | 0.010 |
Why?
|
Stroke | 1 | 2013 | 9755 | 0.010 |
Why?
|
Spine | 1 | 1997 | 1140 | 0.010 |
Why?
|
Models, Genetic | 1 | 2000 | 3447 | 0.010 |
Why?
|
Liver | 2 | 1997 | 7577 | 0.010 |
Why?
|
Planning Techniques | 1 | 1990 | 81 | 0.010 |
Why?
|
Muscles | 1 | 1995 | 1582 | 0.010 |
Why?
|
DNA | 1 | 2003 | 7214 | 0.010 |
Why?
|
Thymus Gland | 1 | 1995 | 1266 | 0.010 |
Why?
|
Incidence | 2 | 1999 | 21538 | 0.000 |
Why?
|
Anticholesteremic Agents | 1 | 1995 | 972 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1997 | 1206 | 0.000 |
Why?
|
Genes, Lethal | 1 | 1988 | 224 | 0.000 |
Why?
|
Organizational Objectives | 1 | 1990 | 426 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4503 | 0.000 |
Why?
|
Diet | 1 | 1985 | 8089 | 0.000 |
Why?
|
Feces | 1 | 1994 | 1511 | 0.000 |
Why?
|
Cognition | 1 | 2003 | 7073 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2001 | 12800 | 0.000 |
Why?
|
Algorithms | 1 | 2006 | 14164 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 74944 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2001 | 19015 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2004 | 16045 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8128 | 0.000 |
Why?
|
Erythrocytes | 1 | 1994 | 2418 | 0.000 |
Why?
|
Mice | 1 | 2011 | 82029 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 20760 | 0.000 |
Why?
|
Program Evaluation | 1 | 1990 | 2507 | 0.000 |
Why?
|
Rats | 1 | 1995 | 23760 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1995 | 5812 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18349 | 0.000 |
Why?
|